West Pharmaceutical Services Inc (WST)vsJIN MEDICAL INTERNATIONAL LTD. Ordinary Shares (ZJYL)
WST
West Pharmaceutical Services Inc
$247.02
+0.71%
HEALTHCARE · Cap: $17.68B
ZJYL
JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares
$1.94
-3.96%
HEALTHCARE · Cap: $303.70M
Smart Verdict
WallStSmart Research — data-driven comparison
West Pharmaceutical Services Inc generates 14760% more annual revenue ($3.07B vs $20.69M). WST leads profitability with a 16.1% profit margin vs 5.8%. WST trades at a lower P/E of 36.1x. WST earns a higher WallStSmart Score of 55/100 (C-).
WST
Buy55
out of 100
Grade: C-
ZJYL
Avoid27
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-256.8%
Fair Value
$68.99
Current Price
$247.02
$178.03 premium
Margin of Safety
-127.0%
Fair Value
$0.07
Current Price
$1.94
$1.87 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Safe zone — low bankruptcy risk
Strong operational efficiency at 21.6%
Reasonable price relative to book value
Areas to Watch
Premium valuation, high expectations priced in
2.1% earnings growth
Expensive relative to growth rate
Smaller company, higher risk/reward
ROE of 4.8% — below average capital efficiency
5.8% margin — thin
Premium valuation, high expectations priced in
Comparative Analysis Report
WallStSmart ResearchBull Case : WST
The strongest argument for WST centers on Altman Z-Score, Operating Margin. Profitability is solid with margins at 16.1% and operating margin at 21.6%.
Bull Case : ZJYL
The strongest argument for ZJYL centers on Price/Book.
Bear Case : WST
The primary concerns for WST are P/E Ratio, EPS Growth, PEG Ratio.
Bear Case : ZJYL
The primary concerns for ZJYL are Market Cap, Return on Equity, Profit Margin. A P/E of 194.0x leaves little room for execution misses.
Key Dynamics to Monitor
WST profiles as a mature stock while ZJYL is a value play — different risk/reward profiles.
ZJYL carries more volatility with a beta of 9.47 — expect wider price swings.
WST is growing revenue faster at 7.5% — sustainability is the question.
WST generates stronger free cash flow (175M), providing more financial flexibility.
Bottom Line
WST scores higher overall (55/100 vs 27/100), backed by strong 16.1% margins. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
West Pharmaceutical Services Inc
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
West Pharmaceutical Services, Inc. is a designer and manufacturer of injectable pharmaceutical packaging and delivery systems. The company is headquartered in Exton, Pennsylvania.
JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
Jin Medical International Ltd. designs and manufactures wheelchairs and living aids products.
Compare with Other MEDICAL INSTRUMENTS & SUPPLIES Stocks
Want to dig deeper into these stocks?